StockData
NYXHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Nyxoah SA

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026
$0.95−0.16 (-14.05%)

Close on Oct 19, 2026

Nyxoah statistics

Financials through Jun 30, 2026, price-based ratios appear once a share price is available

Valuation

Market Cap€36.68M
Enterprise Value-€27.44M
PB Ratio0.44
P/TBV Ratio1.05

Income (trailing twelve months)

Gross Profit€6.33M
Operating Income-€83.49M
Pretax Income-€89.08M
Net Income-€90.09M
EBITDA-€83.49M
EPS (Diluted)-2.36 EUR

Returns

Return on Equity (ROE)-115.1%
Return on Assets (ROA)-63.2%
Return on Invested Capital (ROIC)-189.4%
Return on Capital Employed (ROCE)-68.9%

Balance sheet

Cash & Short-Term Investments€64.12M
Net Cash (Debt)€64.12M
Net Cash Per Share1.49 EUR
Equity (Book Value)€83.11M
Book Value Per Share1.93 EUR
Tangible Book Value€35.09M
Working Capital€65.41M

Financial position

Current Ratio2.38
Quick Ratio1.50
Interest Coverage-7.25

Cash flow (trailing twelve months)

Operating Cash Flow-€68.98M
Capital Expenditures-€805.00K
Free Cash Flow-€69.78M
FCF Per Share-1.62 EUR

Efficiency

Inventory Turnover0.82
Profits Per Employee-€1.80M
Employee Count50

Dividends and yields

Earnings Yield-245.6%
FCF Yield-190.3%
Buyback Yield-56.9%
Shareholder Yield-56.9%

Shares

Shares Outstanding43,026,500
Shares Change (YoY)16.4%
Float31,331,900
Shares Held by Insiders27.2%

Taxes

Income Tax€1.01M

Scores

Altman Z-Score-3.85
Piotroski F-Score2

Calculated by StockData from Nyxoah's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.